OTC ยท Price History

Hiscox Ltd (HCXLY) Price History & Returns

$49.95 OTC: HCXLY Market Cap $8.01B

How Hiscox Ltd (HCXLY) has performed, year by year and over each trailing period. Price history only โ€” total return to a shareholder would also include dividends.

The share price of $49.95 sits 79% of the way up a 52-week range of $36.78 to $53.42; 6.5% below the 52-week high; above its 50-day moving average of $48.45; above its 200-day average of $45.31; a beta of 0.40 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-9.8%
6 months+14.7%
1 year+0.0%
3 years+0.0%
5 years+0.0%
10 years+0.0%

Monthly closing prices

The last 9 months, newest first. 5 of 8 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
October 2026$50.79+6.1%
September 2026$47.86-6.4%
August 2026$51.12+9.9%
July 2026$46.52-6.4%
June 2026$49.68+3.5%
May 2026$47.99+12.7%
April 2026$42.60-2.3%
March 2026$43.62+10.6%
February 2026$39.44โ€”

Hiscox Ltd (HCXLY) price history โ€” frequently asked questions

How has Hiscox Ltd performed over the last year?

Hiscox Ltd (HCXLY) has risen 0.0% over the last twelve months, measured on price alone.

What is Hiscox Ltd's five-year return?

Over five years the HCXLY share price has gained 0.0%, excluding dividends.

What is Hiscox Ltd's 52-week range?

Over the last year Hiscox Ltd (HCXLY) has traded between $36.78 and $53.42.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.